Introduction and Vision Statement: What Do the Frontiers of Thrombosis Reduction Look Like?
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Challenges and Emerging Dimensions of Stroke Prevention in the Setting of Atrial Fibrillation (AF): Achieving Balance Between Thromboprophylaxis and Bleeding Reduction
Gregory Y.H. Lip, MD, FRCP, FACC, FESC

Stroke Prevention in High Risk Populations-The Evolving Paradigm of Warfarin-Based Therapy: Still Relevant? And for How Long?
David A. Garcia, MD

The Emerging Role of Factor Xa and Direct Thrombin Inhibition in Atrial Fibrillation: Mechanisms and Applications for Thrombosis Mitigation Across the CV Disease Spectrum
Richard C. Becker, MD

The Emerging Role of Factor Xa and Direct Thrombin Inhibition for the Setting of Secondary Prevention in Acute Coronary Syndrome (ACS)
Shamir Mehta, MD, MSc, FACC, FRCPC

Summary, Conclusions, and Vision Statement: The Near Future of Thrombosis Reduction in the Setting of ACS and AF
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Faculty Panel: Interactive Question and Answer Session
Faculty Panel